Study guide
6.2 Non-Cardiogenic Shock: Hypovolemic, Distributive and Obstructive
AACN Cardiac Medicine Certification CMC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview and the CMC Test Plan
1.1 CMC Exam Format, Eligibility, Fees & Scoring 1.2 The CMC Test Plan: Four Domains and How to Study Them
2 Chapter 2: Acute Coronary Syndromes and Ischemic Heart Disease
2.1 Pathophysiology & Classification of Acute Coronary Syndromes 2.2 12-Lead ECG Localization & Cardiac Biomarker Trajectories 2.3 Acute Reperfusion Strategies & Nursing Management 2.4 Complications of Acute Myocardial Infarction 2.5 Chronic Coronary Disease, Hyperlipidemia and Lipid-Lowering Therapy
3 Chapter 3: Heart Failure, Cardiomyopathies, Pericardial and Valvular Disease
3.1 Acute Decompensated Heart Failure & Staging 3.2 Acute Cardiogenic Pulmonary Edema 3.3 Dilated, Hypertrophic, and Restrictive Cardiomyopathies 3.4 Acute Pericarditis, Cardiac Tamponade & Constrictive Pericarditis 3.5 Infective Endocarditis, Myocarditis and Rheumatic Heart Disease 3.6 Valvular Heart Disease: Stenosis & Regurgitation 3.7 Syncope: Cardiac Versus Non-Cardiac Causes and Workup
4 Chapter 4: Dysrhythmias, Conduction Disorders and Electrophysiologic Interventions
4.1 Atrial Fibrillation, Atrial Flutter & Supraventricular Tachycardias 4.2 Ventricular Arrhythmias & Cardiac Arrest Management 4.3 Atrioventricular Blocks & Intraventricular Conduction Delays 4.4 Temporary Pacing: Transcutaneous, Transvenous and Epicardial 4.5 Permanent Pacemakers, CRT and Device Troubleshooting 4.6 Implantable and Wearable Cardioverter Defibrillators 4.7 Catheter Ablation and Post-Ablation Nursing Care 4.8 Synchronized Cardioversion and Defibrillation
5 Chapter 5: Vascular Conditions and Vascular Interventions
5.1 Aortic Dissection, Aortic Aneurysms & Hypertensive Crises 5.2 Peripheral Artery Disease & Acute Limb Ischemia 5.3 Acute Venous Thrombosis, DVT and VTE Prophylaxis 5.4 Peripheral and Carotid Angiography and Interventions 5.5 Endovascular Aortic Repair: EVAR and TEVAR 5.6 Catheter-Directed Thrombolysis and Post-Intervention Vascular Complications
6 Chapter 6: Shock States and Mechanical Circulatory Support
6.1 Cardiogenic Shock Pathophysiology, Hemodynamics & Etiologies 6.2 Non-Cardiogenic Shock: Hypovolemic, Distributive and Obstructive 6.3 Multisystem Organ Dysfunction Syndrome 6.4 Intra-Aortic Balloon Pump Therapy & Waveform Optimization 6.5 Percutaneous & Surgical Mechanical Circulatory Support: Impella, VA-ECMO, LVAD
7 Chapter 7: Cardiac Procedures and Structural Heart Interventions
7.1 Diagnostic Cardiac Catheterization & Coronary Angiography Interpretation 7.2 Percutaneous Coronary Intervention: Stents, No-Reflow and Post-PCI Care 7.3 Structural Heart Interventions: TAVR, MitraClip, Pericardiocentesis 7.4 Post-Cardiac Surgery Management (>48 Hours) & Late Complications
8 Chapter 8: Cardiovascular Pharmacology
8.1 Inotropes, Vasopressors & Inodilators 8.2 Vasodilators & Antianginal Agents 8.3 Antiarrhythmic Agents: Vaughan Williams Classes I-IV 8.4 Anticoagulants, Antiplatelets, Thrombolytics & Reversal Agents 8.5 Diuretics and Decongestion Strategies 8.6 Guideline-Directed Medical Therapy for Heart Failure
9 Chapter 9: Non-Cardiovascular Conditions: Pulmonary
9.1 Acute Pulmonary Embolism 9.2 Acute Respiratory Failure and ARDS 9.3 Pleural Space Abnormalities: Pneumothorax, Effusion and Hemothorax 9.4 Pulmonary Hypertension and Right Ventricular Failure 9.5 Sleep-Disordered Breathing in Cardiac Patients
10 Chapter 10: Non-Cardiovascular Conditions: Endocrine, Renal, Hematologic, Neurologic and Behavioral
10.1 Diabetes Mellitus and Glycemic Control in Cardiac Care 10.2 Thyroid and Adrenal Disorders in the Cardiac Patient 10.3 Metabolic Syndrome and Cardiometabolic Risk 10.4 Coagulopathies: Heparin-Induced Thrombocytopenia, DIC and Bleeding Disorders 10.5 Anemia and Transfusion Management in Cardiac Patients 10.6 Acute Ischemic and Hemorrhagic Stroke in the Cardiac Patient 10.7 Acute Kidney Injury and Contrast-Associated Nephropathy 10.8 Chronic Kidney Disease and the Dialysis-Dependent Cardiac Patient 10.9 Electrolyte Imbalances and Dysrhythmia Risk 10.10 Substance Use, Withdrawal and Cardiac Effects 10.11 Non-Cardiac Chest Pain: Differential and Triage 10.12 Non-Cardiovascular Multisystem Complications in Cardiac Patients
11 Chapter 11: Monitoring and Diagnostics
11.1 Pulmonary Artery Catheterization & Hemodynamic Waveform Interpretation 11.2 Arterial Line Monitoring, Continuous Cardiac Output & ScvO2 11.3 Echocardiography, Cardiac MRI & Non-Invasive Cardiac Imaging 11.4 Stress Testing and Myocardial Perfusion Imaging 11.5 Remote Cardiovascular Monitoring and Ambulatory Rhythm Devices 11.6 Laboratory Testing in Cardiac Care 11.7 Arterial Blood Gases and Acid-Base Interpretation 11.8 Pulse Oximetry, Capnography and Chest Radiography
12 Chapter 12: Respiratory, Renal and Multisystem Therapeutic Interventions
12.1 Non-Invasive Ventilation in Cardiac Patients 12.2 Invasive Mechanical Ventilation and Heart-Lung Interactions 12.3 Renal Replacement Therapy: Hemodialysis, CRRT, SCUF and Ultrafiltration 12.4 Targeted Temperature Management After Cardiac Arrest 12.5 Palliative and End-of-Life Care in Advanced Cardiac Disease
6.2 Non-Cardiogenic Shock: Hypovolemic, Distributive and Obstructive
Key Takeaways Explain This Topic AI
The discriminating hemodynamic pattern is high CVP with a normal or low PAOP - that is obstructive or right ventricular shock, not left ventricular failure, and volume or diuresis is the wrong reflex.
Surviving Sepsis 2021 practice is cultures before antibiotics, antimicrobials within 1 hour for septic shock, 30 mL/kg balanced crystalloid, norepinephrine first-line to a MAP of 65 mmHg, vasopressin 0.03 units/min added at norepinephrine 0.25-0.5 mcg/kg/min, and hydrocortisone 200 mg/day for refractory shock.
Anaphylaxis is treated with epinephrine 0.3-0.5 mg IM in the anterolateral thigh; in the beta-blocked cardiac patient who fails to respond, glucagon 1-5 mg IV over 5 minutes bypasses the blocked beta receptor.
Massive transfusion uses a 1:1:1 red cell, plasma, platelet ratio, and citrate-induced ionized hypocalcemia below about 1.0 mmol/L must be replaced with calcium chloride 1 g or calcium gluconate 2-3 g per 2-4 units.
Neurogenic shock is the one shock state presenting with hypotension plus bradycardia and warm, dry, pink skin; MAP is targeted at 85-90 mmHg for 7 days to preserve cord perfusion.
Last updated: August 2026
Why Shock Categorization Is a High-Yield CMC Skill
Test-plan item II.F.2 Shock states sits inside Non-Cardiovascular Conditions, which carries 23% of the CMC blueprint. The exam rarely asks you to define a shock state in the abstract. It hands you a set of pulmonary artery (PA) catheter numbers, a physical exam, and a lactate, and asks what you do next. Because your patient already has a low-output substrate, the discriminating skill is separating non-cardiogenic shock from the cardiogenic shock covered elsewhere in this guide - and recognizing when both are running at once.
Every shock state is a mismatch between oxygen delivery and consumption. Oxygen delivery (DO2) is the product of cardiac output and arterial oxygen content, where arterial content = (1.34 x hemoglobin x SaO2) + (0.003 x PaO2). Only four levers exist: flow, hemoglobin, saturation, and the tissue's ability to extract. The four shock categories differ in which lever failed , and the hemodynamic profile tells you which one.
The Four Hemodynamic Profiles
Shock category CI (L/min/m2) CVP/RAP PAOP SVR (dynes/sec/cm-5) SvO2 Skin
Hypovolemic / hemorrhagic Low (< 2.2) Low (< 2 mmHg) Low (< 8 mmHg) High (> 1,400) Low (< 60%) Cool, pale, delayed refill
Cardiogenic Low (< 2.2) High High (> 18 mmHg) High (> 1,400) Low (< 60%) Cool, mottled
Distributive (septic, warm phase) Normal or high (often > 4.0) Low or normal Low or normal Low (< 800) High (> 75%) Warm, flushed, bounding
- Obstructive - tamponade Low High, equalized High but within 5 mmHg of RA High Low Cool, JVD, pulsus paradoxus
- Obstructive - massive PE / RV failure Low High Normal or low High Low Cool, JVD, clear lungs
Read the table as three questions in order: Is the tank empty? (CVP, PAOP), Is the pump failing? (CI), Is the pipe dilated? (SVR). The single most useful discriminator on the exam is the combination of a high CVP with a normal or low PAOP - that is right ventricular obstruction or failure, not left ventricular failure, and it means the answer is almost never more diuretic. In tamponade, every diastolic pressure equalizes: RA, RV end-diastolic, PA diastolic, and PAOP all land within about 5 mmHg of one another.
Mixed venous oxygen saturation (SvO2, drawn from the PA catheter distal port) is normally 60-80%; central venous saturation (ScvO2, from a superior vena cava line) runs roughly 5-8 points higher. A low SvO2 means delivery has fallen or extraction has risen. A high SvO2 in a patient who is clearly shocked is the fingerprint of failed extraction - septic microcirculatory shunting, cyanide toxicity from prolonged high-dose nitroprusside, a large left-to-right shunt such as a post-infarction ventricular septal rupture, or a permanently wedged catheter sampling arterialized blood.
Hypovolemic and Hemorrhagic Shock
Hypovolemic shock is a preload problem: reduced venous return lowers stroke volume, and compensatory catecholamine release raises heart rate and SVR. In the cardiac patient the compensation itself is dangerous, because tachycardia shortens diastole and raises myocardial oxygen demand in a heart that may already be ischemic.
- Class Blood loss HR Systolic BP Pulse pressure Urine output Mentation
- I < 15% (< 750 mL) < 100 Normal Normal > 30 mL/h Slightly anxious
- II 15-30% (750-1,500 mL) 100-120 Normal Narrowed 20-30 mL/h Mildly anxious
- III 31-40% (1,500-2,000 mL) 120-140 Decreased Narrowed 5-15 mL/h Confused
- IV > 40% (> 2,000 mL) > 140 Decreased Narrowed Negligible Lethargic
The trap is Class II: the blood pressure is still normal, and the only early signals are a narrowing pulse pressure , tachycardia, and a rising base deficit. Waiting for hypotension means waiting for Class III.
Resuscitation. Start with a balanced crystalloid (lactated Ringer's or Plasma-Lyte) rather than 0.9% sodium chloride; large-volume normal saline produces hyperchloremic metabolic acidosis and is associated with more renal adverse events. Crystalloid is a bridge, not a treatment, for hemorrhage - once the loss is roughly 30% or the patient fails to respond to 1-2 L, switch to blood. A massive transfusion protocol delivers packed red cells, plasma, and platelets in a balanced 1:1:1 ratio, which reproduces whole blood more closely than red cells alone and reduces death from exsanguination. Give tranexamic acid within 3 hours of traumatic hemorrhage.
Citrate and calcium are the piece nurses own. Every unit of blood product carries citrate anticoagulant that chelates ionized calcium; in massive transfusion, citrate outstrips hepatic clearance and produces acute ionized hypocalcemia. Ionized calcium below about 1.0 mmol/L causes hypotension, negative inotropy, prolonged QT, and coagulopathy. Replace with calcium chloride 1 g IV (central line preferred) or calcium gluconate 2-3 g IV per 2-4 units transfused, guided by ionized calcium. The classic "lethal triad" of hypothermia, acidosis, and coagulopathy is now more accurately a diamond , with hypocalcemia as the fourth point. Use a fluid warmer and rapid infuser; a cold, acidotic cardiac patient will not clot and will not respond to catecholamines.
Distributive Shock
Septic shock is sepsis with vasopressor-requiring hypotension plus a lactate above 2 mmol/L after adequate fluid resuscitation. Surviving Sepsis Campaign 2021 practice:
Measure lactate and repeat it if elevated; obtain blood cultures before antimicrobials whenever this does not meaningfully delay therapy.
Antimicrobials immediately, ideally within 1 hour , for septic shock or a high likelihood of sepsis; within 3 hours for possible sepsis without shock.
30 mL/kg of IV crystalloid within the first 3 hours, using balanced crystalloid, then dynamic reassessment (stroke volume variation, passive leg raise, echocardiography) rather than fixed further boluses.
Norepinephrine is first-line , titrated to a MAP of 65 mmHg . Start it peripherally rather than delay while a central line is placed.
Add vasopressin 0.03 units/min rather than escalating norepinephrine indefinitely - typically when norepinephrine reaches 0.25-0.5 mcg/kg/min. Epinephrine is the next add-on; dobutamine is added for persistent hypoperfusion with cardiac dysfunction despite adequate MAP and volume.
Hydrocortisone 200 mg/day (50 mg IV every 6 hours or a continuous infusion) for refractory shock - conventionally when norepinephrine or epinephrine is at or above 0.25 mcg/kg/min for at least 4 hours.
The 30 mL/kg number is the single most-tested trap in the cardiac patient. In a patient with an ejection fraction of 20%, severe aortic stenosis, or right ventricular infarction, a reflexive 2-liter bolus produces flash pulmonary edema. The defensible answer is smaller aliquots (250-500 mL) with reassessment after each, early norepinephrine, and invasive or echocardiographic guidance.
Anaphylactic shock. First-line treatment is epinephrine 0.3-0.5 mg of the 1 mg/mL concentration intramuscularly into the anterolateral thigh , repeated every 5-15 minutes; an IV infusion at 0.05-0.1 mcg/kg/min is reserved for refractory cases. Antihistamines and corticosteroids are adjuncts that treat hives, not shock, and must never delay epinephrine. Volume shifts are enormous - up to 35% of intravascular volume can leave the circulation within 10 minutes - so aggressive crystalloid is required. The beta-blocked cardiac patient is the exam scenario : chronic carvedilol or metoprolol blunts the beta response to epinephrine, leaving relatively unopposed alpha stimulation, refractory hypotension, and refractory bronchospasm. The antidote is glucagon 1-5 mg IV over 5 minutes followed by an infusion of 5-15 mcg/min , because glucagon activates adenylate cyclase downstream of the beta receptor. Anticipate vomiting and protect the airway. Observe for a biphasic reaction, which can occur hours after apparent resolution.
Neurogenic shock follows loss of sympathetic outflow after spinal cord injury at or above roughly T6. It is the one shock state with hypotension plus bradycardia , and the skin is warm, dry, and pink below the level of injury with poikilothermia. Treat with fluid plus a vasopressor that has both alpha and beta activity (norepinephrine), not phenylephrine, whose reflex bradycardia worsens the problem; atropine or temporary pacing for symptomatic bradycardia; MAP goal of 85-90 mmHg for the first 7 days to preserve cord perfusion. Do not confuse it with spinal shock , which is the flaccid areflexia of the injured cord and is a neurologic, not hemodynamic, phenomenon.